Legal Sampling Agreement

LEGAL SAMPLING AGREEMENT

This Sampling Agreement (the "Agreement") is entered into as of by and between Company Name: , a organized under the laws of , with principal place of business at ("Provider"), and Recipient Name: , a organized under the laws of , with principal place of business at ("Recipient").

RECITALS

WHEREAS, Provider possesses or controls certain material samples described as (the "Samples");

WHEREAS, Recipient desires to obtain limited access to the Samples for the purpose of and Provider is willing to deliver Samples on the terms set forth herein;

WHEREAS, the parties wish to establish the respective rights, obligations, restrictions on use, and disposition of the Samples and any resulting data or reports.

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties agree as follows:

1. DEFINITIONS

1.1 "Samples" means the physical materials delivered by Provider to Recipient as described in the recitals and in any delivery documentation accompanying the Samples.

1.2 "Confidential Information" means non-public information disclosed by Provider to Recipient relating to the Samples, including composition, formulation, handling instructions, testing protocols, and Results. Confidential Information does not include information that is (a) publicly known through no fault of Recipient, (b) rightfully received from a third party without obligation of confidentiality, or (c) independently developed by Recipient without use of Provider's Confidential Information.

1.3 "Results" means data, analyses, reports, or conclusions generated by Recipient (or its agents) from testing, examination, or evaluation of the Samples.

2. SAMPLE DELIVERY; ACCEPTANCE

2.1 Delivery. Provider shall deliver the Samples to Recipient at the address set forth above by via carrier . The delivery will be accompanied by documentation identifying lot number, quantity, and any handling precautions.

2.2 Acceptance. Recipient will inspect Samples upon receipt and must notify Provider in writing within days of any visible damage or nonconformity. Absent timely notice, Samples will be deemed accepted.

3. PERMITTED USE; TESTING

3.1 Limited License. Provider grants Recipient a non-exclusive, non-transferable, revocable license to use the Samples solely to perform the testing and evaluation activities described in Exhibit A and for no other purpose. No rights in Provider's patents, trade secrets, trademarks, or other intellectual property are granted by this Agreement except as expressly set forth herein.

3.2 Use Restrictions. Recipient shall not (a) reverse engineer, deconstruct, or attempt to derive proprietary formulations from the Samples; (b) sell, distribute, or permit third-party access to Samples except as expressly authorized in writing by Provider; or (c) combine Samples with other materials except as required for authorized testing.

3.3 Subcontracting. Recipient may engage subcontractors to perform testing only with Provider's prior written consent. If Provider consents, Recipient remains responsible for the subcontractor's compliance with this Agreement and must require execution of confidentiality and data protection obligations at least as protective as those in this Agreement. Recipient may subcontract: Yes

4. OWNERSHIP; INTELLECTUAL PROPERTY

4.1 Title. Provider retains all right, title, and interest in and to the Samples and all Confidential Information provided under this Agreement. Nothing in this Agreement transfers ownership of any intellectual property rights from Provider to Recipient.

4.2 Results. Unless otherwise agreed in writing, Provider shall own all Results that directly report the composition or properties of the Samples. Recipient may retain internal analytical data used to generate Results but will not commercially exploit such data without Provider's prior written consent.

5. CONFIDENTIALITY

5.1 Obligation. Recipient shall hold Confidential Information in strict confidence, use at least the same degree of care as it uses to protect its own confidential materials (but not less than reasonable care), and not disclose Confidential Information to any third party except as permitted by this Agreement.

5.2 Term. Recipient's confidentiality obligations shall continue for years from the date of disclosure or until such Confidential Information becomes public through no breach of this Agreement, whichever first occurs.

6. REPORTS; PUBLICATION

6.1 Delivery of Results. Recipient shall provide Provider with a written report of Results within days after completion of testing. Reports shall identify methods used and any deviation from agreed protocols.

6.2 Publication. Recipient shall not publish, present, or otherwise make public any Result or information identifying Provider or the Samples without Provider's prior written consent, which consent may be withheld in Provider's sole discretion. If Provider consents, Provider shall have the opportunity to review and comment on any proposed publication at least days prior to submission.

7. RETURN OR DESTRUCTION OF SAMPLES

Upon expiration or termination of this Agreement, or upon Provider's written request, Recipient shall, at Provider's option, promptly return all remaining Samples to Provider or destroy them and certify destruction in writing. Certification of destruction shall include description of destroyed materials and destruction date: .

8. REPRESENTATIONS; WARRANTIES; LIMITATIONS

8.1 Provider represents that it has the right to provide the Samples to Recipient for the limited purposes set forth herein.

8.2 EXCEPT FOR THE LIMITED REPRESENTATION IN SECTION 8.1, THE SAMPLES ARE PROVIDED "AS IS" AND PROVIDER DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

8.3 LIMITATION OF LIABILITY. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE FOR SPECIAL, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT. EACH PARTY'S AGGREGATE LIABILITY FOR DIRECT DAMAGES SHALL NOT EXCEED .

9. INDEMNIFICATION; INSURANCE

9.1 Indemnity. Recipient shall indemnify, defend, and hold harmless Provider and its officers, directors, and employees from and against any third party claims arising out of Recipient's misuse of the Samples, breach of this Agreement, or negligence in handling the Samples.

9.2 Insurance. Recipient shall maintain commercial general liability and, where applicable, product liability insurance in amounts reasonably sufficient to cover its indemnification obligations, with minimum limits of per occurrence.

10. TERM; TERMINATION

10.1 Term. This Agreement shall commence on the Effective Date and continue until unless earlier terminated under this Section.

10.2 Termination for Cause. Either party may terminate this Agreement for material breach by the other party if the breaching party fails to cure such breach within days after written notice of the breach.

11. COMPLIANCE WITH LAW; HAZARDOUS MATERIALS

11.1 Each party shall comply with all applicable laws and regulations in performing its obligations under this Agreement. Recipient shall handle, store, transport, and dispose of Samples in accordance with applicable law and any handling instructions provided by Provider.

11.2 If Samples are or may be regulated as hazardous, Provider will provide applicable hazard information. Recipient acknowledges receipt of such information: Acknowledged

12. NOTICES

13. AMENDMENT; WAIVER; COUNTERPARTS

This Agreement may be amended or modified only by a writing signed by authorized representatives of both parties. Failure to exercise any right or remedy constitutes a waiver only if such waiver is in writing and signed by the waiving party. This Agreement may be executed in counterparts, each of which shall be an original but all of which together shall constitute one and the same instrument. Electronic signatures shall be binding to the same extent as original signatures.

14. GOVERNING LAW; SEVERABILITY; ENTIRE AGREEMENT

14.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of , without regard to its conflict of law principles.

14.2 Severability. If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect and the parties shall negotiate in good faith to replace the invalid provision with a valid provision that effectuates the parties' intent.

14.3 Entire Agreement. This Agreement, including any exhibits or attachments signed by both parties, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, and communications, whether written or oral.

15. MISCELLANEOUS

15.1 Assignment. Neither party may assign or transfer this Agreement without the prior written consent of the other party, except to a successor in interest in connection with a merger, acquisition, or sale of substantially all assets, provided the successor assumes the assigning party's obligations hereunder.

15.2 Survival. Sections concerning ownership, confidentiality, return or destruction of Samples, indemnification, limitation of liability, and governing law shall survive termination or expiration of this Agreement.

EXHIBIT A — SCOPE OF TESTING (Describe protocols, methods, and acceptance criteria)

Sign Now